THE EFFECT OF OMEPRAZOLE ON THE GASTRIC AND DUODENAL ULCER

[1]  L. Lundell,et al.  Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. , 1991, Scandinavian journal of gastroenterology.

[2]  J. Rehfeld,et al.  Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial. , 1991, Gastroenterology.

[3]  T. Lind,et al.  24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. , 1990, Gastroenterology.

[4]  M. Classen,et al.  Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. , 1989, The New England journal of medicine.

[5]  W. Creutzfeldt,et al.  Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. , 1989, Scandinavian journal of gastroenterology. Supplement.

[6]  L. Sölvell.  The clinical safety of omeprazole. , 1989, Scandinavian journal of gastroenterology. Supplement.

[7]  E. C. Wong,et al.  Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists. , 1989, Journal of gastroenterology and hepatology.

[8]  F. Sundler,et al.  Omeprazole: Its Influence on Gastric Acid Secretion, Gastrin and ECL Cells , 1988, Toxicologic pathology.

[9]  R. Pounder,et al.  Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole , 1987, Alimentary pharmacology & therapeutics.

[10]  U. Haglund,et al.  Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. , 1983, Gut.

[11]  F. Sundler,et al.  Effects of antrectomy or porta‐caval shunting on the histamine‐storing endocrine‐like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study. , 1976, The Journal of physiology.